Tag: Adamis Pharmaceuticals Corp (NASDAQ: ADMP)

Business

Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Offers to Apprise on ZIMHI™

Adamis Pharmaceuticals Corp (NASDAQ: ADMP) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged for appraisal the company’s resubmitted New Drug Application (NDA) for ZIMHI™. FDA finishes filing appraisal and governs NDA adequately ample for fundamental appraisal Adamis has received FDA communication involving the company’s NDA, affirming […]

Business

Will The Development Of Tempo Work For Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Lead to A Sudden Climb In Stock

Adamis Pharmaceuticals Corp (NASDAQ: ADMP) is excited about its rise in stock that stood at 55.7%. Before that, the company stock had declined by 11.50% to settle at $1.00. This “climb,” coupled with its Covid-19 therapy endeavors that seem to be nearing the finish line, continues to inspire hope among […]